Europe - FRA:DC4 - US2521311074 - Common Stock
Taking everything into account, DC4 scores 6 out of 10 in our fundamental rating. DC4 was compared to 59 industry peers in the Health Care Equipment & Supplies industry. DC4 scores excellent on profitability, but there are some minor concerns on its financial health. DC4 is valued quite expensive, but it does show an excellent growth. These ratings would make DC4 suitable for growth investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| ROIC | 14.52% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.22% | ||
| PM (TTM) | 13.29% | ||
| GM | 60.01% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.38 | ||
| Altman-Z | 5.05 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.35 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.76 | ||
| Fwd PE | 27.08 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.89 | ||
| EV/EBITDA | 26.02 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:DC4 (10/24/2025, 7:00:00 PM)
61.38
+0.63 (+1.04%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.76 | ||
| Fwd PE | 27.08 | ||
| P/S | 6.49 | ||
| P/FCF | 48.89 | ||
| P/OCF | 28.25 | ||
| P/B | 10.84 | ||
| P/tB | 11.34 | ||
| EV/EBITDA | 26.02 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| ROCE | 18.43% | ||
| ROIC | 14.52% | ||
| ROICexc | 53.56% | ||
| ROICexgc | 59.66% | ||
| OM | 17.22% | ||
| PM (TTM) | 13.29% | ||
| GM | 60.01% | ||
| FCFM | 13.27% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.38 | ||
| Debt/EBITDA | 1.33 | ||
| Cap/Depr | 176.58% | ||
| Cap/Sales | 9.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.12% | ||
| Profit Quality | 99.88% | ||
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 5.05 |
ChartMill assigns a fundamental rating of 6 / 10 to DC4.DE.
ChartMill assigns a valuation rating of 3 / 10 to DEXCOM INC (DC4.DE). This can be considered as Overvalued.
DEXCOM INC (DC4.DE) has a profitability rating of 8 / 10.
The Earnings per Share (EPS) of DEXCOM INC (DC4.DE) is expected to grow by 26.84% in the next year.